Fisher & Paykel Healthcare Corporation Limited
FPH
株式のランク
#1344
Operating globally, Fisher & Paykel Healthcare Corporation Limited specializes... Operating globally, Fisher & Paykel Healthcare Corporation Limited specializes in the development, manufacturing, and marketing of a wide array of medical device products and systems. These solutions are primarily utilized for acute and chronic respiratory care, during surgical procedures, and in the treatment of obstructive sleep apnea (OSA) within both hospital and home environments. Key offerings include the Airvo 2, a humidified nasal high flow system; Optiflow, for nasal high flow therapy; and the F&P 850 System, which facilitates noninvasive and invasive ventilation. The company also provides a comprehensive range of infant respiratory products, encompassing devices for resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy. Its extensive hospital product portfolio features humidification equipment, breathing circuits, chambers, various masks, nasal cannulas, surgical components, and different interfaces and accessories. For homecare, Fisher & Paykel Healthcare supplies masks, CPAP devices, data management software, humidifiers, and related accessories. Established in 1934, the company is headquartered in Auckland, New Zealand.
株価
$28.18
時価総額
$16.55B
変化（1日）
-4.74%
変化（1年）
37.27%
国
NZ
取引 Fisher & Paykel Healthcare Corporation Limited (FPH)
カテゴリー
Healthcare
Fisher & Paykel Healthcare Corporation Limited（FPH）のP/B比率
2026 時点のP/B比率 TTM: 0
Fisher & Paykel Healthcare Corporation Limited の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
Fisher & Paykel Healthcare Corporation Limited の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
| 年 | P/B比率 | 変化 |
|---|---|---|
| 提供された日付のデータは十分ではありません。 | ||
同業他社のP/B比率
| 企業 | P/B比率 | P/B比率の差 | 国 |
|---|---|---|---|
| 8.1997 | - |
US
|
|
| 1.7417 | - |
FR
|
|
| - | - |
JP
|
|
| 2.1258 | - |
US
|
|
| - | - |
CH
|
